scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMC1013504 |
P8608 | Fatcat ID | release_zd63gc6bl5c7jod4pyzwyncat4 |
P932 | PMC publication ID | 4327944 |
P698 | PubMed publication ID | 21506748 |
P50 | author | Naftali Kaminski | Q41048454 |
P2093 | author name string | Joe G N Garcia | |
Yingze Zhang | |||
Imre Noth | |||
P2860 | cites work | A mutation in the surfactant protein C gene associated with familial interstitial lung disease | Q28201394 |
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. | Q30374030 | ||
A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis | Q40446157 | ||
ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. | Q53314468 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary fibrosis | Q32446 |
idiopathic pulmonary fibrosis | Q2290446 | ||
P304 | page(s) | 1576-1577 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis | |
P478 | volume | 364 |
Q35826595 | A comparison of visual and quantitative methods to identify interstitial lung abnormalities |
Q35902335 | Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis |
Q28298430 | An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias |
Q37149994 | Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations |
Q91605838 | Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility |
Q41437838 | Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes |
Q36464726 | Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis |
Q28291143 | Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis |
Q92931424 | Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent |
Q38030826 | Biomarkers in idiopathic pulmonary fibrosis |
Q37094624 | CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism |
Q35041517 | CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis |
Q27003892 | Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis |
Q26864326 | Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing |
Q41025473 | Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias |
Q37359126 | Epidemiology of idiopathic pulmonary fibrosis |
Q36119163 | Epigenetics in lung fibrosis: from pathobiology to treatment perspective |
Q38205635 | Epigenetics of idiopathic pulmonary fibrosis |
Q27025625 | Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes |
Q38560347 | Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases |
Q35153490 | Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. |
Q64072320 | FGF10-FGFR2B Signaling Generates Basal Cells and Drives Alveolar Epithelial Regeneration by Bronchial Epithelial Stem Cells after Lung Injury |
Q34678023 | Familial Interstitial Pneumonia (FIP). |
Q48037972 | Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis |
Q38103596 | Genetic background of idiopathic pulmonary fibrosis |
Q38210815 | Genetic determinants of pulmonary fibrosis: evolving concepts |
Q36485998 | Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis |
Q28243802 | Genetic susceptibility and pulmonary fibrosis |
Q28943525 | Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study |
Q34479395 | Genetics and early detection in idiopathic pulmonary fibrosis |
Q37596109 | Genome reference and sequence variation in the large repetitive central exon of human MUC5AC. |
Q35239965 | Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course |
Q28943334 | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis |
Q30388977 | Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia |
Q39022184 | Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis. |
Q37563857 | IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER. |
Q57170607 | Idiopathic Pulmonary Fibrosis (IPF): An Overview |
Q93091814 | Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways |
Q38821078 | Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways |
Q41626633 | Idiopathic Pulmonary Fibrosis: A Systemic Disease? |
Q56764887 | Idiopathic pulmonary fibrosis |
Q87721963 | Idiopathic pulmonary fibrosis |
Q52721106 | Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. |
Q35786160 | Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis |
Q47239342 | Insights from human genetic studies of lung and organ fibrosis |
Q57808775 | MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease |
Q36490141 | MUC5B and Idiopathic Pulmonary Fibrosis |
Q52764615 | MUC5B and short telomere length in hypersensitivity pneumonitis. |
Q36132579 | MUC5B expression and location in surfactant protein C mutations in children |
Q47652510 | Mechanisms and Consequences of Oxidative Stress in Lung Disease: Therapeutic Implications for an Aging Populace |
Q38708801 | Microbiome in interstitial lung disease: from pathogenesis to treatment target |
Q64937660 | Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. |
Q27025340 | Molecular biomarkers in idiopathic pulmonary fibrosis |
Q38220769 | Molecular biomarkers in interstitial lung diseases. |
Q26864836 | Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers |
Q34046860 | Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males |
Q38812037 | Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications |
Q64957934 | Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing. |
Q33976506 | Pathogenesis of idiopathic pulmonary fibrosis |
Q34019921 | Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings |
Q26866919 | Personalized medicine: applying 'omics' to lung fibrosis |
Q34558063 | Positional cloning reveals strain-dependent expression of Trim16 to alter susceptibility to bleomycin-induced pulmonary fibrosis in mice |
Q33714064 | Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis |
Q38995612 | Pulmonary fibrosis in the era of stratified medicine. |
Q48150087 | Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis |
Q40058679 | Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype. |
Q39079920 | Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease |
Q36516894 | TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis |
Q42580526 | Taking the "I" out of IPF. |
Q40146154 | The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. |
Q35041524 | The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. |
Q34935466 | The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population |
Q91910333 | The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B |
Q30978345 | The center for causal discovery of biomedical knowledge from big data |
Q38026811 | The genetic and environmental causes of pulmonary fibrosis |
Q40777090 | The genetic basis of idiopathic pulmonary fibrosis |
Q34634190 | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium |
Q33901590 | The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis |
Q57107518 | The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis |
Q36447402 | The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis |
Q90950675 | The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort |
Q50056514 | Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? |
Q91622811 | Translational research in pulmonary fibrosis |
Q55371625 | Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment. |
Q26779192 | Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs |
Q26766313 | Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease |
Search more.